Literature DB >> 10213370

Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers.

D W Miller1, E V Batrakova, A V Kabanov.   

Abstract

PURPOSE: Using monolayers of human pancreatic adenocarcinoma cells (Panc-1) that express multidrug resistance-associated protein (MRP), the present work investigates the effects of Pluronic block copolymers on the functional activity of MRP.
METHODS: The studies examined the accumulation and efflux of the MRP selective probe fluorescein (FLU) in Panc-1 cell monolayers with and without Pluronic P85 (P85), Pluronic L81 (L81) and Pluronic F108 (F108).
RESULTS: Treatment of Panc-1 cells with P85 resulted in concentration-dependent increases in FLU accumulation and elimination of FLU sequestration in vesicular compartments in these cells. The effects of P85 were selective for FLU in the Panc-1 cell monolayers. Inhibition of MRP-mediated transport was dependent on the composition of Pluronic block copolymer: the more hydrophobic copolymer had the greater effect on FLU uptake in Panc-1 monolayers (L81 > P85 > F108).
CONCLUSIONS: This paper demonstrates for the first time that Pluronic block copolymers inhibit multidrug resistance-associated protein (MRP). The similarities in the effects of Pluronic block copolymers on MRP and P-glycoprotein drug efflux systems suggest that a single unifying mechanism may explain the inhibition observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213370     DOI: 10.1023/a:1018873702411

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Block copolymeric biotransport carriers as versatile vehicles for drug delivery.

Authors:  V Y Alakhov; A V Kabanov
Journal:  Expert Opin Investig Drugs       Date:  1998-09       Impact factor: 6.206

2.  Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers.

Authors:  M Fontaine; W F Elmquist; D W Miller
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

3.  Expression pattern of MRP in human tissues and adult solid tumor cell lines.

Authors:  G D Kruh; K T Gaughan; A Godwin; A Chan
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

Review 4.  Multidrug transporters from bacteria to man: similarities in structure and function.

Authors:  H W van Veen; W N Konings
Journal:  Semin Cancer Biol       Date:  1997-06       Impact factor: 15.707

Review 5.  A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum.

Authors:  P G Bray; S A Ward
Journal:  Pharmacol Ther       Date:  1998-01       Impact factor: 12.310

6.  Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump.

Authors:  G Jedlitschky; I Leier; U Buchholz; K Barnouin; G Kurz; D Keppler
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

7.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.

Authors:  L M Breuninger; S Paul; K Gaughan; T Miki; A Chan; S A Aaronson; G D Kruh
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

9.  Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells.

Authors:  Z Holló; L Homolya; T Hegedüs; B Sarkadi
Journal:  FEBS Lett       Date:  1996-03-25       Impact factor: 4.124

10.  Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.

Authors:  M P Draper; R L Martell; S B Levy
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  24 in total

1.  Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles.

Authors:  Robert Luxenhofer; Gaurav Sahay; Anita Schulz; Daria Alakhova; Tatiana K Bronich; Rainer Jordan; Alexander V Kabanov
Journal:  J Control Release       Date:  2011-04-13       Impact factor: 9.776

Review 2.  New technologies for drug delivery across the blood brain barrier.

Authors:  A V Kabanov; E V Batrakova
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 3.  Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery.

Authors:  Hamidreza Montazeri Aliabadi; Mostafa Shahin; Dion R Brocks; Afsaneh Lavasanifar
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (I) effect of polymer hydrophobicity on its ability to protect liposomes from peroxidation.

Authors:  Jia-Yu Wang; Jeremy Marks; Ka Yee C Lee
Journal:  Biomacromolecules       Date:  2012-08-03       Impact factor: 6.988

5.  Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor.

Authors:  J V Aukunuru; G Sunkara; N Bandi; W B Thoreson; U B Kompella
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

6.  Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.

Authors:  E V Batrakova; S Li; D W Miller; A V Kabanov
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

7.  Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.

Authors:  Wendell J Lu; Qing Yang; Li Yang; Dana Lee; David D'Alessio; Patrick Tso
Journal:  Lipids       Date:  2012-06       Impact factor: 1.880

8.  Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).

Authors:  Jing Jin; Min Huang; Huai-Ling Wei; Geng-Tao Liu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

9.  Investigation of the micellar effect of pluronic P85 on P-glycoprotein inhibition: cell accumulation and equilibrium dialysis studies.

Authors:  Naveed Shaik; Nagdeep Giri; William F Elmquist
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.534

Review 10.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.

Authors:  Elena V Batrakova; Alexander V Kabanov
Journal:  J Control Release       Date:  2008-04-24       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.